ScholarIQanswers from OpenAlex & ORCID
Daniel F. Hayes
ResearcherPublications, citations & collaboration network
Daniel F. Hayes is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Daniel F. Hayes have?
ScholarIQindexed works
Daniel F. Hayes has 826 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Daniel F. Hayes have?
ScholarIQcitation count
Daniel F. Hayes has 100,616 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Daniel F. Hayes?
ScholarIQh-index
Daniel F. Hayes has an h-index of 128 in OpenAlex.
What is the i10-index of Daniel F. Hayes?
ScholarIQi10-index
Daniel F. Hayes has an i10-index of 403 in OpenAlex.
What is the ORCID of Daniel F. Hayes?
ScholarIQorcid
The ORCID for Daniel F. Hayes is on the source record.
What is the OpenAlex record for Daniel F. Hayes?
ScholarIQopenalex
The OpenAlex for Daniel F. Hayes is on the source record.
What are the most-cited papers on Daniel F. Hayes?
ScholarIQmost cited works
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
Aron Goldhirsch, Eric P. Winer, Alan S. Coates, Richard D. Gelber, Martine Piccart, Beat Thürlimann, Hans-Jörg Senn, Kathy S. Albain, Fabrice André, Jonas Bergh, Hervé Bonnefoi, Denisse Bretel-Morales, Harold J. Burstein, Fátima Cardoso, Monica Castiglione‐Gertsch, Alan S. Coates, Marco Colleoni, Alberto Costa, Giuseppe Curigliano, Nancy E. Davidson, Angelo Di Leo, Bent Ejlertsen, John Forbes, Richard D. Gelber, Michael Gnant, Aron Goldhirsch, Pamela J. Goodwin, Paul E. Goss, Jay R. Harris, Daniel F. Hayes, Clifford A. Hudis, James N. Ingle, Jacek Jassem, Zefei Jiang, Per Karlsson, Sibylle Loibl, Monica Morrow, Moïse Namer, C. Kent Osborne, Ann H. Partridge, Frédérique Penault‐Llorca, Charles M. Perou, Martine Piccart, Kathleen I. Pritchard, Emiel J. Rutgers, Felix Sedlmayer, Semiglazov Vf, Zhi‐Ming Shao, Ian Smith, Beat Thürlimann, Masakazu Toi, Andrew Tutt, Michael Untch, Giuseppe Viale, Toru Watanabe, Nicholas Wilcken, Eric P. Winer, William C. Wood
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
Lyndsay N. Harris, Herbert A. Fritsche, Robert Mennel, Larry Norton, Peter M. Ravdin, Sheila E. Taube, Mark R. Somerfield, Daniel F. Hayes, Robert C. Bast
Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
M. Dowsett, Torsten O. Nielsen, Roger A’Hern, J. Bartlett, R. Charles Coombes, J Cuzick, Mathew J. Ellis, N. Lynn Henry, Judith Hugh, Tracy Lively, Lisa M. McShane, Seungmok Paik, Frédérique Penault–Llorca, Ludmila Prudkin, MM Regan, Janine Salter, Christos Sotiriou, I E Smith, G. Viale, J. Zujewski, Daniel F. Hayes
Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update
Kimberly H. Allison, M. Elizabeth H. Hammond, Mitch Dowsett, Shannon McKernin, Lisa A. Carey, Patrick L. Fitzgibbons, Daniel F. Hayes, Sunil R. Lakhani, Mariana Chávez‐MacGregor, Jane Perlmutter, Charles M. Perou, Meredith M. Regan, David L. Rimm, W. Fraser Symmans, Emina Torlakovic, Leticia Varella, Giuseppe Viale, Tracey Weisberg, Lisa M. McShane, Antonio C. Wolff
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
Kathy S. Albain, William E. Barlow, Steven Shak, Gabriel N. Hortobágyi, Robert B. Livingston, I‐Tien Yeh, Peter M. Ravdin, Roberto Bugarini, Frederick L. Baehner, Nancy E. Davidson, George W. Sledge, Eric P. Winer, Clifford A. Hudis, James N. Ingle, Edith A. Perez, Kathleen I. Pritchard, Lois E. Shepherd, Julie R. Gralow, Carl Yoshizawa, D. Craig Allred, C. Kent Osborne, Daniel F. Hayes